A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
מצבים רפואיים
Advanced Solid Tumor · Diffuse Large B Cell Lymphoma · Lymphoma, T-Cell · Mesothelioma, Malignant · Prostatic Neoplasms, Castration-Resistant · Endometrial Cancer · Ovarian Clear Cell Carcinoma · Metastatic Castration-resistant Prostate Cancer
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
Emory University School of Medicine, Atlanta, Georgia, United States
Contact: Principal Investigator (Jennifer Scalici, MD)University of Chicago, Chicago, Illinois, United States
Contact: Principal Investigator (Hedy L Kindler, MD)Loyola University Medical Center, Maywood, Illinois, United States
University of Maryland Medical Ctr, Baltimore, Maryland, United States
Massachusetts General Hospital (MGH), Boston, Massachusetts, United States
Contact: Principal Investigator (Ryan Sullivan, MD)Dana Farber Cancer Institute (HARVARD), Boston, Massachusetts, United States
University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States
Hackensack University Medical Center, Hackensack, New Jersey, United States
Roswell Park Cancer Institute, Buffalo, New York, United States
NYU Langone Medical Center, New York, New York, United States
Weill Medical College of Cornell University, New York, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
University of Rochester Medical Center, Rochester, New York, United States
Montefiore Einstein Center for Cancer Care (MECCC), The Bronx, New York, United States
University of Cincinnati Cancer Institute, Cincinnati, Ohio, United States
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Lainie Martin, MD)South Texas Accelerated Research Therapeutics (START) - San Antonio, San Antonio, Texas, United States
South Texas Accelerated Research Therapeutics (START) - Midwest Location, San Antonio, Texas, United States
University of Virginia Health System (UVAHS), Charlottesville, Virginia, United States
Contact: Principal Investigator (Linda Duska, MD)Swedish Cancer Institute, Seattle, Washington, United States
Contact: Principal Investigator (Charles Drescher, MD)Fred Hutchinson Cancer Center, Seattle, Washington, United States
Contact: Principal Investigator (Kalyan Banda, MD)CHU Bordeaux Hopital Saint Andre, Bordeaux, France
CLCC Institut Bergonie, Bordeaux, France
Contact: Principal Investigator (Antoine Italiano)Centre Oscar Lambret, Lille, France
Contact: Principal Investigator (Cyril Abdeddaim)Centre Leon Berard, Lyon, France
Contact: Principal Investigator (Medhi Brahmi)CHU Nantes Hopital Hotel Dieu, Nantes, France
Contact: Principal Investigator (Caroline Viala)CHU Nantes Hopital Hotel Dieu, Nantes, France
Contact: Principal Investigator (Thomas Gastinne)CHU Nantes Hopital Nord Laennec, Saint-Herblain, France
Contact: Principal Investigator (Thomas Gastinne)Institut Cancerologie de Strasbourg, Strasbourg, France
Contact: Principal Investigator (Lauriane Eberst)CLCC Institut Gustave Roussy, Villejuif, France
Contact: Principal Investigator (Vincent Ribrag)Azienda Ospedaliero Universitaria di Bologna - Policlinico S. Orsola-Malpighi, Bologna, Italy
Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy
National Cancer Institute, IRCCS, Milan, Italy
Contact: Principal Investigator (Mara Mantiero)European Institute of Oncology (IEO), IRCCS ( Department of Urogenital and Head-and-Neck Medical Oncology), Milan, Italy
Contact: Principal Investigator (Franco Nole)European Institute of Oncology (IEO), IRCCS, Milan, Italy
Humanitas San Pio X, Milan, Italy
Contact: Principal Investigator (Domenica Lorusso)IRCCS Policlinico Universitario Fondazione Agostino Gemelli, Roma, Italy
Contact: Principal Investigator (Vanda Salutari)IRCCS Istituto Clinico Humanitas - Research Hospital, Rozzano, Italy
Contact: Principal Investigator (Carmelo Carlo-Stella)Uniwersyteckie Centrum Kliniczne GUMed, Gdansk, Poland
Contact: Principal Investigator (Rafal Dziadziuszko)Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy, Gliwice, Poland
Pratia MCM, Krakow, Poland
Institute of Polish Mother Health Centre - ICZMP, Lodz, Poland
Centrum Medyczne Pratia - Poznan, Poznan, Poland
University Teaching Hospital, Poznan, Poland
Contact: Principal Investigator (Radoslaw Madry)Novartis Investigative Site, Daegu, South Korea
National Cancer Center, Goyang-si Gyeonggi-do, South Korea
Gachon University Gil Medical Center, Incheon, South Korea
Contact: Principal Investigator (Kwang-Beom Lee)Seoul National University Hospital, Seoul, South Korea
Contact: Principal Investigator (Jae Weon Kim)Yonsei Univ Health System YUCM, Seoul, South Korea
Contact: Principal Investigator (Jung-Yun Lee)Asan Medical Center, Seoul, South Korea
Contact: Principal Investigator (Shinwha Lee)Gangnam Severance Hospital, Seoul, South Korea
Contact: Principal Investigator (Jae-Hoon Kim)The Catholic University of Korea, Yeouido St. Mary's Hospital, Seoul, South Korea
Hospital Vall d Hebron, Barcelona, Spain
Contact: Principal Investigator (Ana Oaknin Benzaquen)Hospital Clinic of Barcelona, Barcelona, Spain
Contact: Principal Investigator (Begona Mellado Gonzalez)Catalan Institute of Oncology, Barcelona, Spain
Hospital Universitari de Girona Doctor Josep Trueta, Girona, Spain
Contact: Principal Investigator (Maria Pilar Barretina Ginesta)University Hospital Ramon y Cajal, Madrid, Spain
Contact: Principal Investigator (Teresa Alonso Gordoa)University Hospital Clinical San Carlos, Department of Medical Oncology, Madrid, Spain
Contact: Principal Investigator (Jorge Bartolome Arcilla)University Hospital Foundation Jimenez Diaz, Madrid, Spain
Contact: Principal Investigator (Bernard Gaston Doger De Speville Uribe)Hospital Universitario 12 de Octubre, Madrid, Spain
Puerta de Hierro Majadahonda University Hospital, Majadahonda, Spain
Contact: Principal Investigator (Aranzazu Gonzalez-Del-Alba)Hospital Universitario Son Espases, Palma, Spain
Contact: Principal Investigator (Jesus Alarcon Company)Clinica Universidad de Navarra, Pamplona, Spain
Clinica Universidad de Navarra, Pamplona, Spain
Contact: Principal Investigator (Antonio Jose Gonzalez Martin)Hospital Universitario Quirónsalud Madrid, Pozuelo de Alarcón, Spain
Contact: Principal Investigator (Valentina Boni)Parc Taulí Hospital Universitari, Sabadell, Spain
Contact: Principal Investigator (Enrique Gallardo Diaz)Hematology Department - Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain
Santiago Clinic Hospital CHUS, Santiago de Compostela, Spain
Contact: Principal Investigator (Maria Teresa Curiel Garcia)Hospital Virgen del Rocio, Seville, Spain
Contact: Principal Investigator (Alejandro Falcon Gonzalez)Instituto Valenciano de Oncologia, Valencia, Spain
Contact: Principal Investigator (Ignacio Romero Noguera)La Fe University and Polytechnic Hospital, Valencia, Spain
Contact: Principal Investigator (Regina Girones Sarrio)Royal United Hospital Bath NHS Trust, Bath, United Kingdom
Leicester General Hospital, Leicester, United Kingdom
Contact: Principal Investigator (Harriet Walter)Imperial College Healthcare NHS Trust, London, United Kingdom
The Christie NHS Foundation Trust, Manchester, United Kingdom
Churchill Hospital, Oxford, United Kingdom
Southampton General Hospital, Southampton, United Kingdom
The Royal Marsden NHS Foundation Trust - Royal Marsden Hospital (RMH), Sutton, United Kingdom
The Royal Marsden NHS Foundation Trust - Royal Marsden Hospital (RMH), Sutton, United Kingdom
Musgrove Park Hospital, Taunton, United Kingdom
מובילי המחקר
Novartis Pharmaceuticals
Study Director
Novartis Pharmaceuticals